9.4 Preterm Labor, PPROM & Cervical Insufficiency
Key Takeaways
Preterm labor (PTL) is defined as regular uterine contractions (>=4 in 20 minutes or >=8 in 60 minutes) accompanied by progressive cervical change (effacement >=80% or dilation >=2 cm) between 20 0/7 and 36 6/7 weeks gestation.
Clinical evaluation utilizes transvaginal cervical length (short cervix <25 mm before 24 weeks) and fetal fibronectin (fFN; high negative predictive value >95–99% for no delivery within 7–14 days, invalidated by digital exam, intercourse, or bleeding within 24 hours).
Evidence-based pharmacotherapy bundles include antenatal corticosteroids (betamethasone 12 mg IM q24h x 2 doses) between 24 0/7 and 33 6/7 weeks (and late preterm 34 0/7 to 36 6/7 weeks), tocolysis for 48 hours (indomethacin <32 weeks; nifedipine 32–34 weeks), and IV magnesium sulfate for fetal neuroprotection (<32 weeks).
Preterm premature rupture of membranes (PPROM; <37 weeks) is confirmed via sterile speculum exam (pooling, nitrazine blue pH >6.5, microscopic ferning); management involves latency antibiotics (ampicillin + erythromycin/azithromycin; amoxicillin-clavulanic acid strictly avoided) and planned delivery at 34 0/7 weeks or sooner if chorioamnionitis occurs.
Cervical insufficiency presents with painless second-trimester dilation; interventions include history-indicated cerclage (12–14 weeks), ultrasound-indicated cerclage (CL <25 mm before 24 weeks in women with prior preterm birth), or vaginal progesterone for asymptomatic short cervix without prior preterm birth.
Preterm Labor: Diagnostic Criteria & Biomarkers
Preterm labor (PTL) is defined as regular uterine contractions accompanied by cervical change occurring between 20 0/7 and 36 6/7 weeks gestation.
Clinical Diagnostic Criteria
- Documented Uterine Contractions: Persistent, regular contractions occurring at a frequency of ≥4 in 20 minutes or ≥8 in 60 minutes, AND
- Progressive Cervical Change: Documented cervical effacement ≥80% or cervical dilation ≥2 cm upon initial examination.
Screening & Diagnostic Modalities
When patients present with ambiguous or early symptoms (pelvic pressure, menstrual-like cramping, backache, or altered vaginal discharge), two objective diagnostic tools guide clinical triage:
-
Transvaginal Ultrasound Cervical Length (TVUS CL):
- Performed with an empty maternal bladder, obtaining the shortest reproducible measurement along the endocervical canal without excessive probe pressure.
- Normal Cervical Length: Typically measures 35 to 40 mm at 16 to 24 weeks.
- Abnormal / Short Cervix: A cervical length <25 mm before 24 weeks gestation represents a short cervix and strongly correlates with spontaneous preterm birth.
- Clinical Utility: If CL is >30 mm, spontaneous preterm delivery within 7 days is highly unlikely (<1% to 2%), allowing safe discharge.
-
Fetal Fibronectin (fFN):
- Biological Role: An extracellular matrix glycoprotein produced by trophoblast cells that acts as a biological "glue" binding the fetal chorion to the maternal decidua.
- Diagnostic Window: Validated between 22 0/7 and 34 6/7 weeks gestation in symptomatic women with intact membranes and cervical dilation <3 cm.
- Clinical Value: Exceptional Negative Predictive Value (>95% to 99%). A negative fFN (<50 ng/mL) indicates that the patient has a <1% to 5% probability of delivering within the subsequent 7 to 14 days, preventing unnecessary hospitalizations and medication exposure.
- False Positive Precautions: fFN testing is invalidated and prone to false positives if the cervix or posterior fornix has been disrupted within the preceding 24 hours by: digital cervical examination, sexual intercourse, transvaginal ultrasound, moderate-to-heavy vaginal bleeding, or application of vaginal lubricants/creams.
Evidence-Based Pharmacologic Triad in Preterm Labor
When preterm labor is confirmed between 24 0/7 and 33 6/7 weeks gestation, clinical management focuses on administering an evidence-based triad of pharmacotherapies designed to optimize neonatal outcomes.
| Pharmacologic Category | Primary Agent & Dosing | Gestational Window | Clinical Mechanism & Proven Neonatal Benefits |
|---|---|---|---|
| Antenatal Corticosteroids | Betamethasone 12 mg IM q24h × 2 doses, OR Dexamethasone 6 mg IM q12h × 4 doses | 24 0/7 to 33 6/7 weeks (and late preterm 34 0/7 to 36 6/7 weeks) | Accelerates type II pneumocyte maturation and surfactant production. Reduces respiratory distress syndrome (RDS) by 50%, intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), and neonatal death. Optimal efficacy 24h to 7d post-dose. |
| Tocolytic Therapy | Indomethacin (25–50 mg PO q4–6h; max 48h) OR Nifedipine (20 mg PO load, then 10–20 mg q4–6h) | 24 0/7 to 33 6/7 weeks | Relaxes myometrium to prolong pregnancy for 48 hours, providing a critical therapeutic window to complete the corticosteroid course and facilitate maternal transport to a tertiary NICU center. |
| Neuroprotection | Magnesium Sulfate (4 g IV loading dose over 30 min, then 1 g/hr continuous infusion) | <32 0/7 weeks in imminent preterm delivery | Stabilizes neuronal membranes and prevents microvascular reperfusion injury. Drastically reduces the incidence and severity of cerebral palsy and gross motor dysfunction in surviving neonates. |
Tocolytic Agent Selection & Contraindications
- Indomethacin (Non-Steroidal Anti-Inflammatory Drug): First-line tocolytic for gestations <32 weeks. Inhibits cyclooxygenase (COX), blocking prostaglandin synthesis.
- Maternal Side Effects: Mild nausea, gastritis, and platelet dysfunction.
- Fetal Precautions: Prostaglandins maintain fetal ductal patency and renal perfusion. Prolonged use (>48 hours) or administration after 32 weeks can cause premature in utero constriction of the ductus arteriosus (precipitating fetal pulmonary hypertension) and oligohydramnios (secondary to decreased fetal renal output). Treatment is strictly limited to ≤48 hours.
- Nifedipine (Calcium Channel Blocker): First-line tocolytic between 32 0/7 and 33 6/7 weeks (and alternative <32 weeks). Blocks L-type calcium channels in myometrial cells, preventing actin-myosin cross-bridging.
- Maternal Side Effects: Peripheral vasodilation, maternal flushing, headache, dizziness, mild transient hypotension, and reflex tachycardia.
- Terbutaline (Beta-2 Adrenergic Agonist): Utilized for acute, short-term tocolysis (0.25 mg subcutaneously) to treat intrapartum uterine tachysystole. The FDA warns against prolonged subcutaneous or oral maintenance therapy (>48–72 hours) due to severe maternal cardiovascular risks: pulmonary edema, myocardial ischemia, cardiac arrhythmias, and maternal hyperglycemia.
Important
Tocolytic agents do not independently improve long-term neonatal morbidity or mortality, nor do they prolong pregnancy to term. Their sole clinical purpose is to delay delivery for 48 hours, enabling complete antenatal corticosteroid administration and maternal transfer to a facility with a Neonatal Intensive Care Unit (NICU).
Preterm Premature Rupture of Membranes (PPROM)
Preterm premature rupture of membranes (PPROM) refers to spontaneous rupture of the amniotic sac prior to the onset of labor before 37 0/7 weeks gestation. Complications include intra-amniotic infection (chorioamnionitis), umbilical cord prolapse, placental abruption, and neonatal pulmonary hypoplasia.
Diagnostic Evaluation
Diagnostic confirmation relies on a sterile speculum examination:
- Avoid Digital Examination: Digital cervical examination must be strictly withheld in PPROM unless the patient is in active, advanced labor, as digital assessment introduces vaginal pathogens into the endocervix, drastically shortening latency and accelerating chorioamnionitis.
- The Diagnostic Triad:
- Pooling: Direct visualization of clear fluid collecting in the posterior vaginal fornix.
- Nitrazine Test: Amniotic fluid is neutral-to-alkaline (pH 7.1 to 7.3), turning yellow nitrazine paper dark blue (indicating pH >6.5; normal vaginal secretions are acidic, pH 3.8 to 4.5). False positives occur with blood, semen, bacterial vaginosis, or alkaline antiseptic soaps.
- Ferning (Arborization): A drop of fluid allowed to air-dry completely on a clean glass slide demonstrates a delicate palm-leaf or fern-like crystallization pattern under low-power microscopy, driven by high sodium chloride and protein concentrations in amniotic fluid.
Clinical Management Protocol
For stable pregnancies between 24 0/7 and 33 6/7 weeks gestation without maternal or fetal compromise:
- Latency Antibiotic Regimen (7-Day Course): Prolongs latency, decreases chorioamnionitis, and reduces neonatal sepsis, RDS, and IVH:
- Initial 48 Hours: Intravenous Ampicillin (2 g q6h) PLUS Intravenous Erythromycin (250 mg q6h) [or single-dose oral Azithromycin 1 g].
- Subsequent 5 Days: Oral Amoxicillin (250 mg q8h) PLUS Oral Erythromycin (333 mg q8h) [or oral Azithromycin].
- Contraindication Warning: Amoxicillin-clavulanic acid (Augmentin) is strictly contraindicated in PPROM due to a documented, statistically significant increase in neonatal necrotizing enterocolitis (NEC).
- Antenatal Corticosteroids: Single course of betamethasone or dexamethasone administered upon admission.
- Delivery Timing: Expectant management with daily maternal-fetal surveillance is maintained until 34 0/7 weeks gestation, at which point induction of labor is recommended. Immediate delivery is indicated at any gestational age if overt chorioamnionitis (fever ≥39.0°C or ≥38.0°C with uterine tenderness, maternal/fetal tachycardia, or purulent fluid), placental abruption, cord prolapse, or non-reassuring fetal status occurs.
Cervical Insufficiency & Cerclage Indications
Cervical insufficiency is defined as the inability of the uterine cervix to retain a pregnancy in the absence of clinical contractions, labor, or intrauterine infection. It characteristically presents in the second trimester (typically between 14 and 24 weeks) with painless cervical shortening, effacement, and dilation, leading to prolapsing membranes and pregnancy loss.
Etiology & Risk Factors
- Prior mechanical cervical trauma (repeated mechanical dilations during terminations or D&Cs).
- Prior cervical surgical excisions (cold knife cone biopsy or large loop excision of the transformation zone [LEEP]).
- Congenital uterine anomalies (bicornuate or septate uterus) or maternal in utero diethylstilbestrol (DES) exposure.
- Inherited connective tissue disorders (Ehlers-Danlos syndrome).
Management Modalities & Cerclage Placement
| Cerclage Type | Clinical Indication | Timing & Technical Parameters |
|---|---|---|
| History-Indicated Cerclage | History of ≥1 unexplained second-trimester pregnancy loss related to painless cervical dilation, or prior history-indicated cerclage. | Electively placed at 12 to 14 weeks gestation after establishing fetal viability via first-trimester ultrasound. |
| Ultrasound-Indicated Cerclage | Singleton pregnancy with a history of prior spontaneous preterm birth (<34 weeks) who develops a short cervix (CL <25 mm before 24 weeks). | Placed upon sonographic detection between 16 and 23 6/7 weeks gestation. Not recommended in multiple gestations. |
| Physical Exam-Indicated (Rescue) Cerclage | Painless cervical dilation (cervix open 1–4 cm) with visible prolapsing fetal membranes detected on speculum/manual exam in 2nd trimester. | Placed urgently before 24 weeks gestation after ruling out labor, placental abruption, and subclinical intra-amniotic infection. |
Tip
In an asymptomatic woman with a singleton pregnancy and no prior history of spontaneous preterm birth who is incidentally found to have a short cervix (CL ≤20–25 mm) on routine second-trimester ultrasound before 24 weeks, vaginal progesterone (200 mg micronized vaginal suppository daily at bedtime) is the first-line therapy. Cervical cerclage is reserved for women with a history of prior spontaneous preterm birth.
A 29-year-old primigravida at 30 weeks 4 days gestation presents to obstetric triage reporting persistent, rhythmic lower abdominal cramping every 5 minutes for the past 3 hours. Physical examination reveals uterine contractions occurring every 4 to 5 minutes. Sterile speculum examination confirms intact membranes with no visible pooling. Digital cervical examination reveals the cervix is 2 cm dilated and 80% effaced. Fetal heart rate monitoring demonstrates a reactive tracing with a baseline of 140 bpm. Which therapeutic bundle represents the most appropriate, evidence-based management for this patient?
Prescribe oral terbutaline for outpatient tocolysis and recommend strict home bed rest with oral hydration.
Administer betamethasone 12 mg IM, initiate oral indomethacin for 48 hours, and begin intravenous magnesium sulfate for neuroprotection.
Administer oral nifedipine for 7 days, withhold antenatal corticosteroids until 34 weeks, and obtain a rescue cervical cerclage.
Perform immediate emergency cesarean delivery to prevent intraventricular hemorrhage associated with labor.
A 26-year-old G2P1 at 31 weeks 2 days gestation presents to the hospital reporting a sudden, continuous gush of clear fluid from her vagina 2 hours ago. She has no fever, contractions, or abdominal pain. Sterile speculum examination reveals clear amniotic fluid pooling in the posterior fornix that turns nitrazine paper dark blue and demonstrates prominent ferning under microscopy. Electronic fetal monitoring is Category I with no uterine contractions. What is the most appropriate clinical management plan?
Perform a digital cervical examination to assess Bishop score and immediately induce labor with intravenous oxytocin.
Administer a 7-day course of amoxicillin-clavulanic acid (Augmentin) and plan elective cesarean delivery at 32 weeks.
Admit for expectant care with IV ampicillin and erythromycin, antenatal steroids, and planned delivery at 34 0/7 weeks.
Discharge the patient home on strict bed rest and oral cephalexin with instructions to return when active labor begins.
A 31-year-old G2P0 at 19 weeks gestation presents for a routine mid-trimester anatomic ultrasound. Her obstetric history is notable for a prior spontaneous delivery at 21 weeks gestation following painless cervical dilation. Today, transvaginal ultrasonography reveals a singleton intrauterine fetus with normal anatomy, but the cervical length is measured at 18 mm with prominent endocervical funneling. She has no uterine contractions, vaginal bleeding, or symptoms of infection. What is the most appropriate clinical intervention?
Recommend complete pelvic and bed rest until 36 weeks gestation without pharmacologic or surgical intervention.
Initiate daily oral indomethacin 25 mg twice daily until 34 weeks gestation.
Place an emergent rescue cervical cerclage only if the cervical internal os dilates past 4 cm.
Recommend placement of an ultrasound-indicated cervical cerclage before 24 weeks gestation.
Sections you finish are checked off in the contents.